XORTX Therapeutics (XRTX) - 2022 Q3 - Quarterly Report

Exhibit 99.1 CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS For the three and nine months ended September 30, 2022 and 2021 (Unaudited - expressed in Canadian Dollars) XORTX THERAPEUTICS INC. Condensed Interim Consolidated Statements of Financial Position (Unaudited - expressed in Canadian Dollars) | | | September 30, | December 31, | | --- | --- | --- | --- | | | Note | 2022 $| 2021$ | | Assets | | | | | Current | | | | | Cash and cash equivalents | 5 | 12,160,047 | 18,851,244 | | Accounts receivabl ...